Antiangiogenic therapy for advanced renal cell carcinoma: Management of treatment-related toxicities

Por Cohen, Roger B., Oudard, Stéphane
Publicado em 2012

Trial Watch: Therapeutic vaccines in metastatic renal cell carcinoma

Por Combe, Pierre, de Guillebon, Eleonore, Thibault, Constance, Granier, Clémence, Tartour, Eric, Oudard, Stéphane
Publicado no Oncoimmunology (2015)

Complete remission of pulmonary metastases of Bellini duct carcinoma with cisplatin, gemcitabine and bevacizumab

Por Barrascout, Eduardo, Beuselinck, Benoit, Ayllon, Jorge, Bättig, Basil, Moch, Holger, Teghom, Corine, Oudard, Stephane
Publicado em 2012

Is There Still Room for Cancer Vaccines at the Era of Checkpoint Inhibitors

Por Karaki, Soumaya, Anson, Marie, Tran, Thi, Giusti, Delphine, Blanc, Charlotte, Oudard, Stephane, Tartour, Eric
Publicado no Vaccines (Basel) (2016)

Renal malacoplakia: Case report of a differential diagnosis for renal cell carcinoma

Por Ayllon, Jorge, Verkarre, Virginie, Scotté, Florian, Fournier, Laure, Corréas, Jean Michel, Mejean, Arnaud, Teghom, Corine, Oudard, Stéphane
Publicado em 2012

Sorafenib for Older Patients With Renal Cell Carcinoma: Subset Analysis From a Randomized Trial

Por Eisen, Tim, Oudard, Stéphane, Szczylik, Cezary, Gravis, Gwenaelle, Heinzer, Hans, Middleton, Richard, Cihon, Frank, Anderson, Sibyl, Shah, Sonalee, Bukowski, Ronald, Escudier, Bernard
Publicado em 2008

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

Por Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
Publicado em 2011

Risk of Hormone Escape in a Human Prostate Cancer Model Depends on Therapy Modalities and Can Be Reduced by Tyrosine Kinase Inhibitors

Por Guyader, Charlotte, Céraline, Jocelyn, Gravier, Eléonore, Morin, Aurélie, Michel, Sandrine, Erdmann, Eva, de Pinieux, Gonzague, Cabon, Florence, Bergerat, Jean-Pierre, Poupon, Marie-France, Oudard, Stéphane
Publicado em 2012

Neoadjuvant Dose-Dense Gemcitabine plus Docetaxel and Vinorelbine plus Epirubicin for Operable Breast Cancer: Improved Prognosis in Triple-Negative Tumors

Por Medioni, Jacques, Huchon, Cyrille, Le Frere-Belda, Marie-Aude, Hofmann, Henri, Bats, Anne-Sophie, Eme, Denise, Andrieu, Jean-Marie, Oudard, Stéphane, Lecuru, Fabrice, Levy, Eric
Publicado em 2012

High Milk Consumption Does Not Affect Prostate Tumor Progression in Two Mouse Models of Benign and Neoplastic Lesions

Por Bernichtein, Sophie, Pigat, Natascha, Capiod, Thierry, Boutillon, Florence, Verkarre, Virginie, Camparo, Philippe, Viltard, Mélanie, Méjean, Arnaud, Oudard, Stéphane, Souberbielle, Jean-Claude, Friedlander, Gérard, Goffin, Vincent
Publicado no PLoS One (2015)

Early objective response may not be a prognostic factor of survival for patients with metastatic urothelial carcinoma: from a retrospective analysis of a cohort of 113 patients

Por Roubaud, Guilhem, Brouste, Véronique, Beuzeboc, Phillipe, Fléchon, Aude, Tosi, Diego, Lavau-Denes, Sandrine, Chevreau, Christine, Culine, Stéphane, Oudard, Stéphane, Quivy, Amandine, Pourquier, Philippe, Houédé, Nadine
Publicado no J Negat Results Biomed (2015)

Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Men Treated With Second-Line Chemotherapy

Por Halabi, Susan, Lin, Chen-Yen, Small, Eric J., Armstrong, Andrew J., Kaplan, Ellen B., Petrylak, Daniel, Sternberg, Cora N., Shen, Liji, Oudard, Stephane, de Bono, Johann, Sartor, Oliver
Publicado em 2013

Expression of EPHRIN-A1, SCINDERIN and MHC class I molecules in head and neck cancers and relationship with the prognostic value of intratumoral CD8(+) T cells

Por Hasmim, Meriem, Badoual, Cécile, Vielh, Philippe, Drusch, Françoise, Marty, Virginie, Laplanche, Agnès, de Oliveira Diniz, Mariana, Roussel, Hélène, De Guillebon, Eléonore, Oudard, Stéphane, Hans, Stéphane, Tartour, Eric, Chouaib, Salem
Publicado em 2013

Autologous dendritic cell immunotherapy (DCVAC/PCa) added to docetaxel chemotherapy in a Phase III trial (viable) in men with advanced (mCRPC) prostate cancer

Por Beer, Tomasz M, Vogelzang, Nicholas, Bartůňková, Jiřina, Miller, Kurt, Oh, William, Oudard, Stephane, Pandha, Hardev, Sartor, A Oliver, Špíšek, Radek, Toole, Timothy O, Borgstein, Niels G, Gerritsen, Winald R
Publicado no J Immunother Cancer (2015)

Prognostic and theranostic impact of molecular subtypes and immune classifications in renal cell cancer (RCC) and colorectal cancer (CRC)

Por Becht, Etienne, Giraldo, Nicolas A, Beuselinck, Benoit, Job, Sylvie, Marisa, Laetitia, Vano, Yann, Oudard, Stéphane, Zucman-Rossi, Jessica, Laurent-Puig, Pierre, Sautès-Fridman, Catherine, de Reyniès, Aurélien, Fridman, Wolf Herman
Publicado no Oncoimmunology (2015)

Outcomes in elderly patients admitted to the intensive care unit with solid tumors

Por Auclin, Edouard, Charles-Nelson, Anaïs, Abbar, Baptiste, Guérot, Emmanuel, Oudard, Stéphane, Hauw-Berlemont, Caroline, Thibault, Constance, Monnier, Alexandra, Diehl, Jean-Luc, Katsahian, Sandrine, Fagon, Jean-Yves, Taieb, Julien, Aissaoui, Nadia
Publicado no Ann Intensive Care (2017)

Denosumab and Bone Metastasis–Free Survival in Men With Nonmetastatic Castration-Resistant Prostate Cancer: Exploratory Analyses by Baseline Prostate-Specific Antigen Doubling Time...

Por Smith, Matthew R., Saad, Fred, Oudard, Stephane, Shore, Neal, Fizazi, Karim, Sieber, Paul, Tombal, Bertrand, Damiao, Ronaldo, Marx, Gavin, Miller, Kurt, Van Veldhuizen, Peter, Morote, Juan, Ye, Zhishen, Dansey, Roger, Goessl, Carsten
Publicado em 2013

Clinical and Experimental Progression of a New Model of Human Prostate Cancer and Therapeutic Approach

Por de Pinieux, Gonzague, Legrier, Marie-Emmanuelle, Poirson-Bichat, Florence, Courty, Yves, Bras-Gonçalves, Rui, Dutrillaux, Anne-Marie, Némati, Fariba, Oudard, Stéphane, Lidereau, Rosette, Broqua, Pierre, Junien, Jean-Louis, Dutrillaux, Bernard, Poupon, Marie-France
Publicado em 2001

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group

Por Oudard, Stéphane, Elaidi, Reza, Brizard, Mara, Rest, Céline Le, Caillet, Valérie, Deveaux, Sophie, Benoit, Gérard, Corréas, Jean-Michel, Benoudiba, Farida, David, Philippe, Gaudric, Alain, Hammel, Pascal, Joly, Dominique, Timsit, Marc Olivier, Méjean, Arnaud, Richard, Stéphane
Publicado no Oncotarget (2016)

Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: long term outcome of the Temporary Authorization for Use programme in France

Por Houédé, Nadine, Beuzeboc, Philippe, Gourgou, Sophie, Tosi, Diego, Moise, Laura, Gravis, Gwenaëlle, Delva, Remy, Fléchon, Aude, Latorzeff, Igor, Ferrero, Jean-Marc, Oudard, Stéphane, Tartas, Sophie, Laguerre, Brigitte, Topart, Delphine, Roubaud, Guilhem, Agherbi, Hanane, Rebillard, Xavier, Azria, David
Publicado no BMC Cancer (2015)